IPH (IPH) Company Presentation summary
Event summary combining transcript, slides, and related documents.
Company Presentation summary
6 Jun, 2025Strong investment proposition
Holds leading patent and trademark group positions in Australia, Canada, New Zealand, and Singapore, with 1,800+ employees and 34,000+ annual patent filings.
Demonstrates consistent revenue and EBITDA growth, with FY24 revenue at $609.9m and underlying EBITDA at $195.5m; cash conversion remains high and dividends stable.
Maintains a diverse earnings base across patents, trademarks, and legal services, with significant presence in Australia, New Zealand, Canada, and Asia.
Global trends in IP
IP protection remains critical amid global technology competition, trade tensions, and deglobalisation, driving increased patent filings and licensing activity.
China leads in AI-related patent filings, accounting for about 70% of global share by 2023; generative AI patents have surged over 800% since 2014.
IPH is embedding AI in operational workflows, focusing on patent drafting, automation, and productivity tools.
Regional performance and strategy
Australia/New Zealand: Organic earnings growth continues, with focus on higher-margin international filers and increased inbound Chinese patent filings.
Asia: Patent filings up 17% FY25 YTD; Singapore market share rises to 22.2%; targeting growth from Chinese tech innovation and cross-border opportunities.
Canada: CIPO system delays have impacted revenue, but recovery and fee catch-up expected from FY26; Bereskin & Parr integration completed, exceeding synergy targets.
Latest events from IPH
- Earnings and cash flow rose, driven by Canada and Asia, with ANZ impacted by US PCT declines.IPH
H1 202619 Feb 2026 - Strong FY24 growth, Canadian expansion, and improved leverage support future outlook.IPH
H2 202423 Jan 2026 - Strong growth, Canadian expansion, and transformation initiatives drive future momentum.IPH
AGM 202414 Jan 2026 - Underlying EBITDA up 11% and net profit up 20% on strong growth and integration.IPH
H1 202523 Dec 2025 - Revenue up 16.5% to AUD 710.3m, with cost savings and Canadian integration driving future growth.IPH
H2 202523 Nov 2025 - Profit growth, board renewal, and CEO succession amid U.S. and Canadian market challenges.IPH
AGM 202520 Nov 2025 - IPH acquires Bereskin & Parr, expanding in Canada and launching a major equity raise.IPH
Investor Presentation13 Jun 2025